Key Findings From Recent Trials

• INN (International Nonproprietary Name): Vardenafil
• Brand Names Available In United Kingdom: Levitra (film‑coated tablets and ODT in EU/EEA markets) and various generic vardenafil products sold under private labels and by e‑pharmacies.
• ATC Code: G04BE09
• Forms & Dosages: Film‑coated tablets 5 mg, 10 mg and 20 mg; Orally Disintegrating Tablet (ODT) commonly in 10 mg only.
• Manufacturers In United Kingdom: Bayer Pharma was the original EU supplier; multiple generic manufacturers supply vardenafil tablets and ODTs globally and to UK channels.
• Registration Status In United Kingdom: Prescription‑only medicine across OECD markets; product information previously authorised via EMA for EU/EEA and subject to national regulatory routes for UK supply.
• OTC / Rx Classification: Prescription Only (Rx) in the EU, USA and OECD countries, not available over the counter.
• Standard Dosages Per Condition: Erectile Dysfunction (Adult) — 10 mg oral approximately 60 minutes before sexual activity; maximum one tablet per 24 hours.
• Dosage Adjustments: Not indicated for children under 18; elderly (≥65 years) generally start at 5 mg; mild–moderate liver impairment usually start 5 mg; severe hepatic impairment not recommended; renal impairment requires caution in severe disease.
• Treatment Duration: On‑demand use prior to planned sexual activity rather than daily dosing.
• Missed Dose And Overdose Instructions: Missed dose not applicable; overdose requires emergency care — possible severe hypotension, visual disturbance or priapism.
• Storage & Transport: Store at room temperature (15–30°C) in original packaging; protect from moisture and light.
• Absolute Contraindications: Concurrent nitrates (including recreational “poppers”), known hypersensitivity to vardenafil, severe liver impairment, recent stroke or myocardial infarction, and concomitant riociguat use.
• Relative Contraindications: Severe renal impairment, penile anatomical deformities, significant cardiovascular disease and conditions predisposing to priapism.
• Common Side Effects: Headache, flushing, nasal congestion, dyspepsia and dizziness; rare reports of vision change, back or muscle pain.

What did recent trials and analyses actually show about vardenafil?

Clinical attention from 2022 to 2025 focused on formulation performance — notably ODT versus film‑coated tablets — and real‑world tolerability rather than brand‑new efficacy claims.

Regulatory product information and EMA summaries continue to support vardenafil’s established efficacy for erectile dysfunction when dosed correctly.

The standard adult starting dose remains 10 mg taken about 60 minutes before sexual activity with a maximum of one tablet per 24 hours.

Clinicians increasingly favour lower initial dosing (5 mg) for patients aged 65 and over or for those with hepatic or renal impairment.

ODT formulations are preferred when swallowing is an issue or when onset speed is prioritised.

Reported safety signals remain consistent with long‑standing experience: headache, flushing, nasal congestion and dyspepsia are the most frequent adverse events.

Severe events such as priapism and sudden vision loss are rare but are listed as emergency risks in product information.

These observations align with EMA and manufacturer guidance on contraindications and monitoring for vardenafil and other PDE5 inhibitors.

Clinical Mechanism Of Action

Layman’s Explanation

How does vardenafil help with erectile dysfunction?

Vardenafil relaxes the smooth muscle in the blood vessels of the penis so that blood can flow in more easily during sexual stimulation.

It is not an aphrodisiac and will not produce an erection without sexual arousal or stimulation.

Scientific Breakdown

Vardenafil is a selective phosphodiesterase‑5 (PDE5) inhibitor (ATC G04BE09) used to treat erectile dysfunction.

By inhibiting PDE5 it prolongs cyclic GMP (cGMP) signalling in corporal smooth muscle cells.

That prolongation enhances nitric oxide‑mediated vasodilation and increases penile blood inflow sufficient for erection when sexual stimulation is present.

Typical onset for film‑coated tablets is around 60 minutes after oral dosing.

ODT forms (commonly 10 mg) are designed for rapid administration and may allow quicker or more convenient dosing for patients with swallowing difficulties.

Hepatic impairment and severe renal disease affect vardenafil handling and require dose modification or avoidance per product guidance.

Elderly patients generally start at 5 mg to assess tolerability before any upward titration.

Mechanistic risks include additive vasodilation with nitrates or riociguat, which can cause severe hypotension and are absolute contraindications to vardenafil use.

Scope Of Approved And Off‑Label Use

United Kingdom Approvals

What is vardenafil licensed for in the UK context?

Vardenafil is an approved PDE5 inhibitor for male erectile dysfunction and is available as branded and generic tablets via prescription channels.

Levitra has an EU/EEA approval history and vardenafil products are prescription‑only across OECD countries.

Generics and private‑label vardenafil tablets are commonly supplied through community pharmacies and licensed e‑pharmacies.

Notable Off‑Label Trends

Do clinicians use vardenafil for anything other than ED?

Some clinicians have explored vardenafil in research settings for lower urinary tract symptoms or pulmonary hypertension, but these are off‑label and require specialist oversight.

On‑demand dosing (single tablet within 24 hours) remains the standard approach; daily regimens are uncommon unless managed by a specialist.

Always verify current MHRA status and the licensed summary of product characteristics for the specific vardenafil product you intend to prescribe or dispense.

Dosage Strategy

General Dosing

Patients commonly ask: “What dose should I start on?”

The standard adult dose for erectile dysfunction is 10 mg taken orally approximately 60 minutes before sexual activity.

Do not exceed one tablet in any 24‑hour period.

Film‑coated tablets are available in 5 mg, 10 mg and 20 mg strengths; ODTs are typically supplied as 10 mg units.

Condition‑Specific Dosing

Elderly patients (age 65 and over) typically start at 5 mg and titrate up only if needed and tolerated.

Mild to moderate hepatic impairment usually prompts a 5 mg starting dose; severe hepatic impairment is generally not recommended for vardenafil.

Renal impairment management depends on severity — mild to moderate disease may use standard or reduced dosing while severe renal disease requires specialist input and cautious dosing.

Counsel patients clearly on on‑demand use, the 24‑hour single‑dose limit, and avoidance of nitrates at all times.

Safety Protocols

Contraindications

Is it safe for everyone?

Absolute contraindications include concurrent nitrate therapy such as nitroglycerin and isosorbide mononitrate or dinitrate and recreational alkyl nitrites (“poppers”).

Other absolute contraindications include known hypersensitivity to vardenafil or excipients, severe liver impairment, recent stroke or myocardial infarction, and co‑administration with riociguat.

Relative contraindications that require monitoring include severe renal impairment, penile anatomical deformities and significant cardiovascular disease.

Adverse Effects

What should patients expect?

Common mild to moderate adverse effects include headache, flushing, nasal congestion, dyspepsia and dizziness.

Less common reactions are visual disturbances, back pain and muscle pain.

Emergency warnings include priapism — an erection lasting longer than four hours — and sudden vision or hearing loss, which require urgent medical attention.

Mitigation starts with a thorough medication review and cardiovascular risk assessment prior to prescribing.

Interaction Mapping

Food Interactions

Can food affect how vardenafil works?

Vardenafil may be taken with or without food, but a high‑fat meal can delay absorption and slow the onset of action.

ODT formulations may provide a more predictable onset when timing is critical or when patients have difficulty swallowing.

Drug Combinations To Avoid

Which drugs should never be combined with vardenafil?

Concomitant nitrates are an absolute contraindication because the combination can cause profound, life‑threatening hypotension.

Riociguat is also contraindicated due to synergistic effects on blood pressure.

Strong CYP3A4 inhibitors — for example ketoconazole or ritonavir — increase vardenafil exposure and may require dose reduction or avoidance.

Potent CYP3A4 inducers can reduce effectiveness.

Combining vardenafil with other antihypertensives may potentiate falls in blood pressure and requires assessment of baseline blood pressure.

Recreational use of nitrates or unregulated “ED polypharmacy” markedly increases the risk of serious adverse events.

Patient Experience Analysis

Survey Data

Do patients like vardenafil?

UK and European patient surveys show high satisfaction with PDE5 inhibitors when patients receive appropriate counselling.

Vardenafil is often praised for consistent efficacy and the convenience of an ODT option for those with swallowing issues.

Common patient concerns include headache, timing the dose around meals or alcohol, and cardiovascular safety.

Forum Trends

What do online forums say?

Forum threads frequently discuss generic vardenafil 20 mg and listings labelled “Levitra Professional.”

Users commonly emphasise verifying product legitimacy, prescription status and sourcing from regulated pharmacies.

Many forum posts ask clinicians to confirm cardiovascular safety before use, which highlights the value of shared decision‑making and clear counselling.

Distribution And Pricing Landscape

Where can patients obtain vardenafil and what affects price?

In the UK vardenafil is prescription‑only and available as branded and generic tablets via NHS prescriptions where clinically indicated, private clinics, community pharmacies and licensed e‑pharmacies.

Brand presence varies and generics or private‑label ODTs are commonly used to meet demand.

Pricing drivers include strength (5/10/20 mg), formulation (film‑coated versus ODT), pack size and whether the supply is on the NHS or privately obtained.

E‑pharmacy listings sometimes use terms like “Levitra Professional”; verify MHRA registration and pharmacy accreditation before purchase.

In our online pharmacy, levitra professional is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.

Alternative Options

Comparison Table

Which PDE5 alternatives should clinicians consider?

Sildenafil (Viagra), tadalafil (Cialis) and avanafil (Spedra/Stendra) are the main comparators in the UK market.

Sildenafil is well known and widely available with an onset around 30–60 minutes and a side‑effect profile similar to vardenafil.

Tadalafil offers a much longer duration of action — up to 36 hours — which suits patients seeking greater spontaneity.

Avanafil may offer a faster onset for some patients and can be useful where rapid onset is important.

Pros And Cons

Choose sildenafil if familiarity and cost are priorities.

Choose tadalafil if a prolonged window for sexual activity is desired and the patient accepts the potential for longer‑lasting adverse effects.

Choose avanafil for potentially quicker onset, subject to availability and patient comorbidities.

Vardenafil remains a niche choice for patients who value ODT convenience and predictable potency, with dose selection tailored to comorbidities and interacting medicines.

Regulatory Status

What is the regulatory position for vardenafil?

Vardenafil falls under ATC code G04BE09 in the PDE5 inhibitor group.

EMA records show vardenafil products, including Levitra formulations, have historic EU approvals and authorised product information is available via EMA public documents.

Post‑Brexit regulation for UK supply is MHRA‑based and vardenafil products remain prescription‑only in the UK.

Levitra has been discontinued in some markets, for example in parts of the USA, while generics and ODT formulations remain available globally.

Always check the MHRA and the licensed product leaflet for current UK marketing authorisations and SPC details before prescribing or dispensing.

Consolidated FAQ

Quick Answers For Clinicians And Patients

• Is vardenafil prescription‑only in the UK? Yes — prescription only; verify MHRA leaflets and local formularies.
• Typical starting dose? 10 mg about 60 minutes before sexual activity; elderly or hepatic impairment often start at 5 mg.
• Can you take it daily? On‑demand use is standard; daily regimens are not routine unless a specialist suggests otherwise.
• Major contraindication? Concurrent nitrates and riociguat are absolute contraindications; severe hepatic impairment is usually avoided.
• Storage? Store at room temperature (15–30°C) in the original blister pack to protect from moisture and light.

Provide these answers in plain language and remind patients about emergency signs such as priapism or sudden vision or hearing loss.

Visual Guide

Pill Identification And Packaging Notes

How can patients or pharmacists identify vardenafil products?

Vardenafil is supplied as film‑coated tablets in 5 mg, 10 mg and 20 mg strengths and as ODTs commonly in 10 mg.

Pill markings, colour and shape vary by manufacturer so document strength imprint, blister labelling, expiry and batch numbers at dispensing.

Keep blister packaging until the medication is used or returned to pharmacy, as it helps verify authenticity.

ODT Versus Film‑Coated Practical Differences

ODT tablets dissolve on the tongue and are useful for patients with dysphagia or for discreet dosing without water.

Film‑coated tablets offer a wider range of strengths for easier dose titration.

In practice, choose ODT when swallowing or rapid administration is a priority, and choose film‑coated options when multiple strength options are helpful for titration.

Storage And Transport

What are the correct storage and transport practices?

Store vardenafil at room temperature (15–30°C) in original blister packaging away from moisture and light.

When transporting or shipping, avoid prolonged exposure to heat or humidity and keep blisters intact.

Pharmacies should document batch and expiry details on dispensing records as standard practice.

Dispose of unused vardenafil via pharmacy take‑back services rather than household waste or flushing down the toilet.

E‑pharmacies shipping internationally must respect UK export/import rules and ensure patient safety checks are completed before dispatch.

Guidelines For Proper Use

Prescribing Checklist

What should prescribers confirm before issuing a vardenafil prescription?

Confirm an erectile dysfunction diagnosis and suitability for a PDE5 inhibitor.

Review cardiovascular history and all current medications, focusing on nitrates, riociguat and strong CYP3A4 inhibitors.

Assess liver and renal function and choose the formulation and dose (5/10/20 mg) based on those factors.

Document informed consent and any known contraindications and advise patients against purchasing from unregulated sources.

Patient Counselling Points

What should patients be told at supply?

Explain on‑demand dosing — one tablet per 24 hours — and timing of approximately 60 minutes before activity.

Discuss possible food effects, especially with high‑fat meals, and the impact of alcohol on function and blood pressure.

Set clear expectations for common side effects such as headache and flushing and explain emergency signs (priapism, sudden vision/hearing loss).

Arrange follow‑up to review efficacy and tolerability and consider dose adjustment if needed.

Refer to MHRA or licensed product leaflets if there is uncertainty about specific product details.

Delivery Across United Kingdom

Final Notes For Clinicians And Pharmacists

When prescribing or dispensing vardenafil document the chosen product name and strength, including whether the supply is an ODT or film‑coated tablet.

Always check for interacting medicines and counsel patients about contraindications, especially nitrates and riociguat.

Encourage patients to keep blister packs for identification and to use regulated UK pharmacies rather than unverified online sellers.

Report any suspected severe adverse reactions according to Yellow Card procedures in the UK.

For patients seeking alternatives discuss sildenafil, tadalafil and avanafil as options and tailor choice to lifestyle, comorbidity and potential drug interactions.